23
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Immunoregulation of Encephalitogenic MBP-NAc1-11-Reactive T Cells by CD4+ TCR-Specific T Cells Involves IL-4, IL-10 and IFN-γ

, , , , &
Pages 237-248 | Received 04 Aug 1999, Published online: 02 Mar 2012

References

  • Putcrson, P.Y. Experimental allergic encephalomyelitis and autoimmune disease. Adv. Immunol. 1986: 5: 131.
  • Pcttinelli, C.B. and McFarlin. D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt-1.2+ T lymphocytes. J. Immunol. 1981; 127: 1420.
  • Miller, S.D. and Karpus, W.J. The immunopathogenesis and regulation of T-ccll-mcdiated dcmyelinating diseases. Immunol. Today 1994; 15: 356–361.
  • Sclmaj. K.W. and Raine, C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988; 23: 339–346.
  • Karpus, W.J. and Swanborg, R.H. CD4+ suppressor cells inhibit the function of effector cells of EAE through a mechanism involving transforming growth factor-beta. J. Immunol. 1991; 146: 1163–1168.
  • Cua, D.J., Hinton, D.R. and Stohlman. S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-rcsistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 1995: 155: 4052.
  • Kuchroo, V.K., Das, M.P., Brown, J.A. Ranger. A.M., Zamvil, S.S., Sobel, R.A. et al. B7-1 and B7-2 costimula-tory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707.
  • Shaw, M.K., Lorens, J.B., Dhawan, A. DalCanto. R. Tsc, H.Y., Tran. A.B. et al. Local delivery of intcrleukin 4 by rctrovirus-transduccd T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. .y/j. Med. 1997; 185: 1711.
  • Burns, F.R., Li, X., Shcn. N. Offner. H. Chou. Y. Vandcnbark, A.A. et al. Both rat and mouse T cell receptors specific for the cnccphalitogenic determinant of myelin basic protein use similar V and V/9 chain genes even though the major histocompatibility complex and cnccphalitogenic determinants being recognized are different. J. Exp. Med. 1989; 169: 27 39.
  • Vandcnbark, A.A., Hashim, G. and Offner. H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541 544.
  • Offner. H.. Hashim. G.A. and Vandcnbark. A.A. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991; 251: 430 432.
  • Howell. M.D., Winters. ST.. Olee. T., Powell. H.C.. Carlo. D.J. and Brostoff. S.W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science (Wash. DC) 1989; 246: 668–670.
  • Offncr. H.. Adlard. K.. Bebo Jr. B.F., Schuster. J., Burrows. G.G., Bucnafc. A.C. el al. Vaccination with BV8S2 protein amplifies TCR specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice. J. Immunol. 1998: 161: 2178–2186.
  • Vandenbark. A.A.. Hashim. G.A. and Offner. H. T cell receptor peptides in treatment of autoimmune disease: rationale and potential.J. New-osci. Res. 1996:43: 391–402.
  • Weinberg. A.D.. Celnik, B., Vainicne. M.. Bucnafc. A.C. Vandenbark. A.A. and Offner. H. The effect of TCR V/38 peptide therapy on T cell populations isolated from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J. Newoiinmunol. 1994:49: 161.
  • Kumar, V. and Sercarz. E.E. The involvement of T cell receptor peptidc-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 1993: 178: 909–916.
  • Kumar. V.. Tabibiazar, R., Gcysen, H.M. and Sercarz. E. Immunodominant framework region 3 peptide from TCR V/38.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 1995; 154: 1941–1950.
  • Kumar. V. and Sercarz. E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide specific regulatory CD4 T cells. J. Immunol. 1998: 161: 6585–6591.
  • Kennedy. M.K. Torrance, D.S., Picha. K.S. and Mohler. K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-I0 mRNA expression correlates with recovery. J. Immunol. 1992: 149: 2496–2505.
  • Kumar. V.. Stellrecht, K. and Sercarz, E. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 1996; 184: 1609–1617.
  • Siklodi. B.. Jacobs. R.. Burrows, G.G.. Vandenbark. A.A. and Offner. H. Neonatal exposure of TCR BV8S2 transgenic mice to recombinant TCR BV8S2 results in reduced T cell proliferation and elevated antibody response to BV8S2 and increased severity of EAE., /. New-osci. Res. 1998; 52: 750.
  • Goverman, J., Woods, A., Larson. L., Werner, L.P. and Zallcr. D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993; 72: 551–560.
  • Vainicne, M., Burrows, G.G.. Ariail, K., Robey. 1. Vandenbark. A.A. and Offner. H. Neonatal injection of Lewis rats with recombinant V/38.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996: 45: 475–486.
  • Hashim. G.A.. Day, E.D.. Frcdanc. L., Intintola. P. and Carvalho, E. Biological activity of region 65 to 102 of the myelin basic protein. J. Neurosci. Res. 1986: 16: 467.
  • Voorthuis. J.A.C.. Uitdehaag. B.M.J.. DcGroot. C.J.A.. Goedc. P.H., VanDcrMeide. P.H. and Dijkstra. CD. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interfcron-gamma in Lewis rats. Clin. Exp. Immunol. 1990; 81: 183. "
  • Billiau. A., Heremans. H., Vandekerckhove, F.. Dijkmans. R.. Sobis. H.. Meulepas, E. el al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 1988: 140: 1506.
  • Duong, T.T. Finkelman. F.D. Singh. G. and Strcjan. G.H. Effect of anti-interfcron-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 1994; 53: 101.
  • O'Garra, A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998: 8: 275.
  • Chou. Y.K.. Weinberg. A.D.. Bucnafc. A.. Bourdette, D.N.. Whitham. R.. Kaleeba, J.A.R. el al. MHC-rcstriction. cytokine profile, and immunorcgulatory effects of human T cells specific for TCR VB CDR2 peptides: comparison with myelin basic protein-specific T cells. J. Neurosci. Res. 1996:45: 838 851.
  • Vandenbark. A.A.. Chou. Y.K., Whitham. R., Mass. M., Buenafe. A.. Liefcld, D. el al. Treatment of multiple sclerosis with T cell receptor peptides: results of a double-blind pilot trial. Nature Med. 1996; 2: 1109–1115.
  • Vandenbark. A.A.. Chou. Y.K.. Bourdette. D.N.. Whitham. R. and Offner. H. Therapeutic application of T cell receptor peptides. Drug News Persp. 1997: 10: 341 346.
  • Kumar. V.. Sercarz. E. and Adorini. L. Regulatory mechanisms in organ-specific autoimmunity. The Immu-no/ogisl 1998; 6: 161–166.
  • Zhang. J., Mcdacr. R.. Stinisscn, P.. Haflcr. D.A. and Raus. J.CM. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993:261: 1451–1454.
  • Lehmann, P.V. Forsthubcr. T. and Sercarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoanligcn. Nature 1992; 358: 155 157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.